Immune Response in Subjects With Fabry Disease Who Are Switching From Agalsidase Alfa to Agalsidase Beta
Clinical trial NCT01745185 · COMPLETED
Trial details
- NCT number
- NCT01745185
- Sponsor
- O & O Alpan LLC
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2012-06-01
- Primary completion
- 2015-04-07
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.